Source: Weill Cornell Medical College
06.20.2007
Research led by scientists at Weill Cornell Medical College has uncovered two new potential points of vulnerability on a key cancer-promoting protein, called XIAP. Drugs that target either of these activities could help push cancer cells back into a more regular programmed cell death and thereby reduce or eliminate tumors.
External Link: http://news.med.cornell.edu/wcmc/wcmc_2007/06_20c_07.shtml
